State Of Wisconsin Investment Board C4 Therapeutics, Inc. Transaction History

State Of Wisconsin Investment Board

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$1.81 - $3.89 $255,934 - $550,046	-141,400 Reduced 82.4%	30,200 $56,000
Q2 2023 Aug 14, 2023	BUY	$2.75 - $3.77 $85,712 - $117,503	31,168 Added 22.19%	171,600 $471,000
Q1 2023 May 15, 2023	BUY	$3.1 - $9.02 $17,849 - $51,937	5,758 Added 4.28%	140,432 $440,000
Q4 2022 Feb 14, 2023	BUY	$5.42 - $10.24 $125,299 - $236,728	23,118 Added 20.72%	134,674 $794,000
Q3 2022 Nov 14, 2022	BUY	$8.03 - $12.77 $45,184 - $71,856	5,627 Added 5.31%	111,556 $978,000
Q2 2022 Aug 15, 2022	BUY	$5.06 - $26.46 $310,830 - $1.63 Million	61,429 Added 138.04%	105,929 $799,000
Q2 2021 Aug 12, 2021	BUY	$30.39 - $42.18 $1.35 Million - $1.88 Million	44,500 New	44,500 $1.68 Million

130

63.5M

670K

54.8K

Ticker CCCC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,913,800
Market Cap $178M
Description
C4 Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins for the treatment of cancer, neurodegenerative conditions, and other diseases. Its lead product candidate is CFT7455, an orally bioavailable MonoDAC degrader of protein that is in Phase 1/2 trial targeting ...

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

Stay updated on State Of Wisconsin Investment Board with notifications on news.